Answers are grounded in this paper and cite their sources.
This review summarizes traditional and emerging therapies for SLE. Evidence suggests that the heterogeneity of SLE is a crucial aspect contributing to the failure of large clinical trials for new targeted therapies. A clearer understanding of the mechanisms driving disease pathogenesis combined with recent advances in medical science are predicted to enable accelerated progress towards improved SLE diagnosis and personalized approaches to treatment.
No takes yet. Share an insight, caveat, or question.
Davis et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: